Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: Canada Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20023
20034
20043
20052
20063
20074
20087
200912
20103
20113
20129
20137
20148
20158
20162
20173
20183
20194
20202
20215
20222
202310
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Terminated19
Active, not recruiting18
Recruiting16
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
National Cancer Institute (NCI)8
University Health Network, Toronto7
AbbVie6
Gilead Sciences6
BeOne Medicines5
Celgene5
Janssen Research & Development, LLC5
NCIC Clinical Trials Group5
Loxo Oncology, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell124
Lymphoma, Non-Hodgkin29
Lymphoma, Follicular24
Lymphoma, Mantle-Cell23
Lymphoma, B-Cell, Marginal Zone21
Precursor Cell Lymphoblastic Leukemia-Lymphoma21
Lymphoma20
Lymphoma, Large B-Cell, Diffuse20
Recurrence20
Waldenstrom Macroglobulinemia18

Trials

Showing 26 to 50 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.